Sunday, July 13, 2025

COL1A2 Gene Polymorphisms Show Limited Impact on Osteoporosis Risk in Women

Similar articles

A comprehensive study of 570 postmenopausal women delved into the relationship between COL1A2 gene variations and bone density. The investigation revealed that although the rs17166249 T allele appeared more frequently among osteoporosis sufferers, the genetic markers did not significantly correlate with bone mineral measurements after adjusting for other factors.

Genetic Variations Analyzed

Researchers focused on two specific polymorphisms within the COL1A2 gene: rs17166249 and rs412777. Utilizing real-time PCR with targeted primers and TaqMan probes, the study meticulously examined the distribution of these genetic variants across different participant groups, including those diagnosed with osteoporosis, osteopenia, and healthy controls.

Subscribe to our newsletter

Key Findings and Implications

The study found no significant differences in the distribution of genotypes and alleles for rs412777 among the groups. While the rs17166249 T allele was more prevalent in the osteoporosis group, the association lost statistical significance after accounting for confounding variables. Additionally, no meaningful correlations emerged between the genotypes of either SNP and various BMD parameters such as T-score, Z-score, and overall BMD measurements.

  • The rs17166249 T allele showed a higher prevalence in osteoporosis patients before adjustment.
  • No significant association was found for rs412777 polymorphism.
  • Genetic factors alone may not be sufficient to predict BMD variations.

The findings suggest that COL1A2 gene variations may have a modest effect on bone health, but their role in influencing osteoporosis risk is not definitive. This underscores the complexity of osteoporosis as a multifactorial disease influenced by both genetic and environmental factors. Future research should aim to explore a broader range of genetic markers and consider interactions with lifestyle and environmental variables to better understand the risk factors associated with bone density loss in postmenopausal women.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article